EUVIMEDEUVIMED entdecken
Open Access

The N6‐Methyladenosine‐Modified CIT Promotes Uterine Corpus Endometrial Carcinoma Progression by Inhibiting the Hippo Signaling Pathway

Yuehong Tong, Lili Xu, YiQun Sun, Keke Zhang, Xiaoyan Fu iD

Immunology & Cell Biology · 2026

DOI: 10.1111/imcb.70152 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunology & Cell Biology, 2026. Verfasst von Yuehong Tong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynaecology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang, China. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Protein Serine-Threonine Kinases, Adenosine. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: the Key Project of Social Development Category in Jinhua Science and Technology Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigates the role of CIT gene in uterine corpus endometrial carcinoma (UCEC) progression, focusing on its regulation by m6A methylation. Bioinformatics and experimental analyses (EdU, colony formation assay, Dot blot, MeRIP‐PCR, RNA pull‐down, qRT‐PCR, Western Blotting, apoptosis assay) revealed that CIT was significantly overexpressed in UCEC. Mechanistically, we found that the m6A writer RBM15‐mediated CIT mRNA methylation, which was then recognized by the reader IGF2BP1 to enhance CIT mRNA stability and expression. Consequently, this m6A‐mediated upregulation of CIT inhibited the Hippo signaling pathway, ultimately suppressing apoptosis and promoting malignant proliferation in UCEC. These findings elucidated a novel RBM15/IGF2BP1‐CIT‐Hippo axis, providing new theoretical insights and potential therapeutic targets for UCEC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endometrial NeoplasmsProtein Serine-Threonine KinasesAdenosineFemaleHumansHippo Signaling PathwayDisease ProgressionGene Expression Regulation, NeoplasticSignal TransductionRNA-Binding ProteinsRNA MethylationCell ProliferationCell Line, TumorApoptosisAnimalsRNA, Messenger

Stichwörter der Autor:innen

CITN6‐methyladenosinehippo signaling pathwayuterine corpus endometrial carcinoma

Substanzen

Protein Serine-Threonine KinasesN-methyladenosineAdenosineRNA-Binding ProteinsRNA, Messenger

Autor:innen und Institutionen

  • Department of Gynaecology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang, China.
  • Department of Gynaecology, Jinhua Maternal and Child Health Care Hospital, Jinhua, Zhejiang, China.
  • Medical Molecular Biology Laboratory, Medical College, Jinhua University of Vocational Technology, Jinhua, Zhejiang, China.

ORCID-Profile: Xiaoyan Fu

Förderung

  • the Key Project of Social Development Category in Jinhua Science and Technology Plan

Zitieren

APA

Tong, Y., Xu, L., Sun, Y., Zhang, K., & Fu, X. (2026). The N6‐Methyladenosine‐Modified CIT Promotes Uterine Corpus Endometrial Carcinoma Progression by Inhibiting the Hippo Signaling Pathway. Immunology & Cell Biology. https://doi.org/10.1111/imcb.70152

Vancouver

Tong Y, Xu L, Sun Y, Zhang K, Fu X. The N6‐Methyladenosine‐Modified CIT Promotes Uterine Corpus Endometrial Carcinoma Progression by Inhibiting the Hippo Signaling Pathway. Immunology & Cell Biology. 2026. doi:10.1111/imcb.70152

BibTeX
@article{Tong2026,
  author = {Tong, Yuehong and Xu, Lili and Sun, YiQun and Zhang, Keke and Fu, Xiaoyan},
  title = {The N6‐Methyladenosine‐Modified CIT Promotes Uterine Corpus Endometrial Carcinoma Progression by Inhibiting the Hippo Signaling Pathway},
  journal = {Immunology & Cell Biology},
  year = {2026},
  doi = {10.1111/imcb.70152}
}
Kostenlos starten →